Comparison of the Effects of Protocols Applied After Surgical Extraction of Impacted Mandibular Third Molars
Launched by BATMAN UNIVERSITY · Mar 22, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
The mandibular third molars are the most commonly impacted teeth in the jaws, and their surgical extraction is a frequently performed procedure in oral and maxillofacial surgery clinics. Postoperative pain, trismus, and edema, particularly within the first 48 hours after surgery, significantly impair patients' quality of life. In addition to routinely prescribed medications, various postoperative treatment methods have been explored to minimize or control these complications. Some of the methods reported in the literature include corticosteroid administration, low-level laser therapy, hyalu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients classified as American Society of Anesthesiologists (ASA) Class I or II
- • Age range of 18-35 years
- • Individuals of both genders
- • Horizontally impacted teeth with the same angulation according to Winter's classification
- Exclusion Criteria:
- • Patients with any pathological condition around the impacted tooth
- • Pregnant or breastfeeding women
- • Smokers
- • Individuals with allergic reactions to the adjuvants or prescribed medications used in the study
- • Surgical extraction procedures exceeding 30 minutes
About Batman University
Batman University is a leading academic institution dedicated to advancing healthcare research and innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts clinical trials aimed at exploring cutting-edge therapies and improving patient outcomes. Leveraging its state-of-the-art facilities and a team of renowned researchers, Batman University is committed to ethical research practices and the dissemination of knowledge to enhance the understanding of various medical conditions. Through its rigorous scientific approach, the university strives to contribute significantly to the field of medicine and improve the health of communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diyarbakır, Sur, Turkey
Patients applied
Trial Officials
Nedim GÜNEŞ, Ass.Prof.
Study Chair
Dicle University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported